Pharmacists are finally eligible to get government support on repaying their student loans if they go to work in communities that are underserved by primary care providers.
Congressional approval of the bipartisan Generic Drug and Biosimilars User Fee Act could eliminate 90% of the backlog of Abbreviated New Drug Applications by 2017, FDA official Russell Wesdyk, BS, MBA, said in a presentation last month.
California pharmacists would be able to better assist patients with increasingly more complicated over-the-counter assessment tests if the state?s Senate approves new legislation, according to Jon Roth, CEO, California Pharmacists Association.
The recent passage of a Kentucky bill prohibiting pharmacy benefit managers from recouping payments through pharmacy audits when there is no evidence of fraud bodes well for similar federal legislation, according to a recent statement from the National Association of Chain Drug Stores.
CMS's proposed regulation for long-term care consultant pharmacists is stirring up controversy.
The business formula for success is simple and has withstood the test of time.
Continuing legal battles between the Drug Enforcement Administration and Cardinal Health have raised questions about federal drug policy and the role of distributors.
Because pharmacists are making a measurable difference in the outcomes of their patients, their roles as providers are changing. There are some barriers, however.
Patients can serve as checkpoints to guide drug development down the most efficient path.
Readers speak out about the need for pharmacists to change their work environment, job satisfaction in the hospital pharmacy setting, and obesity drugs.